Education
About Us
Working with TipRanks
Follow Us
BONESUPPORT HOLDING AB (DE:2B4)
FRANKFURT:2B4
Earnings Data
Report Date
Apr 22, 2026TBA (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
―Last Year’s EPS
0.02Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presented a broadly positive operational and financial picture: strong underlying sales growth (especially CERAMENT G in the U.S.), high gross margins, solid adjusted profitability and cash generation, plus continued geographic and product expansion (spine launch, De Novo path for CERAMENT V). Offsetting risks include currency translation headwinds that depressed reported growth, headwinds in Germany, rising commercial costs and distributor fees, newly introduced U.S. tariffs, and regulatory timing/uncertainty around CERAMENT V. Early-stage adoption in many newly opened accounts is still developing and some segments (spine, revision arthroplasty) require more evidence. Overall, the positives materially outweigh the challenges, with the company signaling confidence in 2026 constant-currency growth guidance (at least ~35%).Company Guidance
Strong Quarterly Revenue Growth
Net sales for Q4 reached ~SEK 312–313 million, up 22% year-over-year reported and up 36% at constant exchange rates. Last-12-month reported growth was ~31% (40% at constant FX). Antibiotic-eluting CERAMENT products grew ~54% LTM in constant currency.
CERAMENT G U.S. Momentum
CERAMENT G U.S. sales reached SEK 207 million in the quarter (versus SEK 154 million a year earlier). U.S. sales overall grew ~40% at constant exchange rates, driven by new accounts, wider adoption among existing accounts and improving sales per working day. Distribution expanded to >140 Level 1 trauma centers (from 15 at end-2024), establishing a strong launch footprint.
Healthy Profitability and Cash Generation
Adjusted operating result (ex long‑term incentive effects) was ~SEK 81 million, with an adjusted operating margin of ~26% (FX-adjusted margin ~27% vs 22.6% prior year). Reported operating result was ~SEK 81.8 million. Operating cash flow remained robust at SEK 54 million and gross margin stayed high at ~95% (minor decline noted).
Product and Market Expansion
Early-stage U.S. launch of CERAMENT BVF in spine was initiated. Regulatory work progressed as CERAMENT V U.S. submission was moved to the De Novo pathway (positioning the product for a distinct category). Europe & RoW sales of SEK 54 million showed 18% growth at constant FX; hybrid markets (Southern Europe, Australia, Canada) showed strong performance. India and Japan remain strategic market targets with India launch expected H1 2026.
Clinical & Access Progress
Broader clinical traction: expansion from foot & ankle into trauma and revision arthroplasty with encouraging pilot data (e.g., Charité) and collaborations (e.g., Oxford Bone Infection Unit). Investments in commercial programs (EUROW booster) and focused training/support are accelerating access and adoption.
DE:2B4 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:2B4 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 24, 2026 | €16.26 | €16.26 | 0.00% |
Oct 23, 2025 | €23.48 | €22.42 | -4.51% |
Jul 15, 2025 | €26.38 | €27.36 | +3.71% |
Apr 24, 2025 | €28.92 | €28.02 | -3.11% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does BONESUPPORT HOLDING AB (DE:2B4) report earnings?
BONESUPPORT HOLDING AB (DE:2B4) is schdueled to report earning on Apr 22, 2026, TBA (Confirmed).
What is BONESUPPORT HOLDING AB (DE:2B4) earnings time?
BONESUPPORT HOLDING AB (DE:2B4) earnings time is at Apr 22, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of BONESUPPORT HOLDING AB stock?
The P/E ratio of BONESUPPORT HOLDING AB is N/A.
What is DE:2B4 EPS forecast?
Currently, no data Available